Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Use this SYRE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SYRE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SYRE SEC filings page. Lician reads the product cache first so this HTML stays unique to Spyre Therapeutics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full SYRE income, balance, and cash tables.